BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 19915147)

  • 1. Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival.
    Bogunovic D; O'Neill DW; Belitskaya-Levy I; Vacic V; Yu YL; Adams S; Darvishian F; Berman R; Shapiro R; Pavlick AC; Lonardi S; Zavadil J; Osman I; Bhardwaj N
    Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20429-34. PubMed ID: 19915147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma.
    Weiss SA; Han SW; Lui K; Tchack J; Shapiro R; Berman R; Zhong J; Krogsgaard M; Osman I; Darvishian F
    Hum Pathol; 2016 Nov; 57():116-125. PubMed ID: 27473267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-L1 Negative Status is Associated with Lower Mutation Burden, Differential Expression of Immune-Related Genes, and Worse Survival in Stage III Melanoma.
    Madore J; Strbenac D; Vilain R; Menzies AM; Yang JY; Thompson JF; Long GV; Mann GJ; Scolyer RA; Wilmott JS
    Clin Cancer Res; 2016 Aug; 22(15):3915-23. PubMed ID: 26960397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune cells in the melanoma microenvironment hold information for prediction of the risk of recurrence and response to treatment.
    Camisaschi C; Vallacchi V; Castelli C; Rivoltini L; Rodolfo M
    Expert Rev Mol Diagn; 2014 Jul; 14(6):643-6. PubMed ID: 24914691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response.
    Mihm MC; Clemente CG; Cascinelli N
    Lab Invest; 1996 Jan; 74(1):43-7. PubMed ID: 8569196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of aging on host immune response and survival in melanoma: an analysis of 3 patient cohorts.
    Weiss SA; Han J; Darvishian F; Tchack J; Han SW; Malecek K; Krogsgaard M; Osman I; Zhong J
    J Transl Med; 2016 Oct; 14(1):299. PubMed ID: 27760559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Expression Profiling Prognostication of Posterior Uveal Melanoma: Does Size Matter?
    Binkley EM; Bena JF; Davanzo JM; Hinz C; Boldt HC; Singh AD
    Ophthalmol Retina; 2020 Jun; 4(6):620-629. PubMed ID: 32081600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-infiltrating lymphocytes and mitotic index in metastatic melanoma as predictors of patient survival.
    Murali R; Scolyer RA
    Proc Natl Acad Sci U S A; 2010 Mar; 107(13):E46; author reply E47. PubMed ID: 20308534
    [No Abstract]   [Full Text] [Related]  

  • 9. A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis.
    Hanniford D; Zhong J; Koetz L; Gaziel-Sovran A; Lackaye DJ; Shang S; Pavlick A; Shapiro R; Berman R; Darvishian F; Shao Y; Osman I; Hernando E
    Clin Cancer Res; 2015 Nov; 21(21):4903-12. PubMed ID: 26089374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic lesions with and without interleukin-18-dependent genes in advanced-stage melanoma patients.
    Crende O; Sabatino M; Valcárcel M; Carrascal T; Riestra P; López-Guerrero JA; Nagore E; Mandruzzato S; Wang E; Marincola FM; Vidal-Vanaclocha F
    Am J Pathol; 2013 Jul; 183(1):69-82. PubMed ID: 23707237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients.
    Zager JS; Gastman BR; Leachman S; Gonzalez RC; Fleming MD; Ferris LK; Ho J; Miller AR; Cook RW; Covington KR; Meldi-Plasseraud K; Middlebrook B; Kaminester LH; Greisinger A; Estrada SI; Pariser DM; Cranmer LD; Messina JL; Vetto JT; Wayne JD; Delman KA; Lawson DH; Gerami P
    BMC Cancer; 2018 Feb; 18(1):130. PubMed ID: 29402264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour-infiltrating lymphocytes and expression of programmed death ligand 1 (PD-L1) in melanoma brain metastases.
    Berghoff AS; Ricken G; Widhalm G; Rajky O; Dieckmann K; Birner P; Bartsch R; Höller C; Preusser M
    Histopathology; 2015 Jan; 66(2):289-99. PubMed ID: 25314639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanoma.
    Fröhlich A; Loick S; Bawden EG; Fietz S; Dietrich J; Diekmann E; Saavedra G; Fröhlich H; Niebel D; Sirokay J; Zarbl R; Gielen GH; Kristiansen G; Bootz F; Landsberg J; Dietrich D
    EBioMedicine; 2020 Feb; 52():102647. PubMed ID: 32028068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global microarray profiling identified
    Weng Q; Chen M; Li M; Zheng YF; Shao G; Fan W; Xu XM; Ji J
    J Med Genet; 2019 Jan; 56(1):32-38. PubMed ID: 30120213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory cell infiltrates in advanced metastatic uveal melanoma.
    Krishna Y; McCarthy C; Kalirai H; Coupland SE
    Hum Pathol; 2017 Aug; 66():159-166. PubMed ID: 28655639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of tumor-infiltrating lymphocytes (TILs) as a predictive biomarker of response to anti-PD1 therapy in patients with metastatic non-small cell lung cancer or metastatic melanoma.
    Uryvaev A; Passhak M; Hershkovits D; Sabo E; Bar-Sela G
    Med Oncol; 2018 Jan; 35(3):25. PubMed ID: 29388007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistence of regression and tumor infiltrating lymphocytes is associated with more favorable survival in melanoma.
    Tas F; Erturk K
    J Cancer Res Clin Oncol; 2021 Sep; 147(9):2721-2729. PubMed ID: 33611652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2010 TNM staging system for cutaneous melanoma...and beyond.
    Gershenwald JE; Soong SJ; Balch CM;
    Ann Surg Oncol; 2010 Jun; 17(6):1475-7. PubMed ID: 20300965
    [No Abstract]   [Full Text] [Related]  

  • 19. Data mining of immune-related prognostic genes in metastatic melanoma microenvironment.
    Han W; Huang B; Zhao XY; Shen GL
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33169786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: a retrospective study.
    Shibutani M; Maeda K; Nagahara H; Fukuoka T; Matsutani S; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M
    BMC Cancer; 2018 Apr; 18(1):371. PubMed ID: 29614981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.